Broncus Technologies develops and sells innovative solutions for diagnosing and treating lung diseases. The Company’s LungPoint® system allows physicians to plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its FleXNeedle™ catheter is used to obtain biopsy samples and access to hard-to-reach targets.
On 22, October, 2012, LifeTech Scientific Corporation, DiNova Venture Partners, and
Themes Investment Partners, and Broncus Technologies, announced a global strategic
partnership through the formation of Broncus Medical.
Following a recent strategic partnership with Medtronic, the acquisition will allow LifeTech Scientific to increase revenue generation from a novel technology as well as launch into a large and growing market (China). Today, LifeTech Scientific is worth over ‘6x’ its value from the time of the transaction.
Healthios (Third500) served as exclusive adviser to Broncus Technologies.
This transaction highlights Healthios (Third500) commitment to creative deal
structure capitalizing on company milestones and market opportunity while
considering shareholder interest.
If you would like to learn more information about this transaction contact us below.